A novel anticancer chromeno-pyrimidine analogue inhibits epithelial-mesenchymal transition in lung adenocarcinoma cells

References

• Abdelhafez OM, Amin KM, Batran RZ, Maher TJ, Nada SA, Sethumadhavan S. 2010. Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives. Bioorg Med Chem. 18(10):3371–3378.
   PubMed Web of Science ®Google Scholar
• Akrami H, Safavi M, Mirjalili BF, Ashkezari MD, Dadfar F, Mohaghegh N, Emami S, Salehi F, Nadri H, Ardestani SK, et al. 2017. Facile synthesis and antiproliferative activity of 7H-benzo[7,8]chromeno[2,3-d]pyrimidin-8-amines. Eur J Med Chem. 127:128–136.
   PubMed Web of Science ®Google Scholar
• Alblewi FF, Okasha RM, Hritani ZM, Mohamed HM, El-Nassag MAA, Halawa AH, Mora A, Fouda AM, Assiri MA, Al-Dies AM, et al. 2019. Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene. Bioorg Chem. 87:560–571.
   PubMed Web of Science ®Google Scholar
• Al-Majedy YK, Al-Amiery AA, Kadhum AAH, Mohamad AB. 2016. Antioxidant activities of 4-methylumbelliferone derivatives. PLoS One. 11(5):e0156625.
   PubMed Web of Science ®Google Scholar
• Al-Warhi T, Sabt A, Elkaeed EB, Eldehna WM. 2020. Recent advancements of coumarin-based anticancer agents: an up-to-date review. Bioorg Chem. 103:104163
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Bubols GB, da Rocha Vianna D, Medina-Remon A, von PG, Lamuela-Raventos RM, EiflerLima VL, Garcia SC. 2013. The antioxidant activity of coumarins and flavonoids. Mini Rev Med Chem. 13(3):318–334.
   PubMed Web of Science ®Google Scholar
• Budzisz E, Brzezinska E, Krajewska U, Rozalski M. 2003. Cytotoxic effects, alkylating properties and molecular modeling of coumarin derivatives (I) and their phosphonic analogues (II) and (III). chemInform. Eur J Med Chem. 38(6):597–603.
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Weinberg RA. 2011. A perspective on cancer cell metastasis. Science. 331(6024):1559–1564.
   PubMed Web of Science ®Google Scholar
• Chia CY, Kumari U, Casey PJ. 2014. Breast cancer cell invasion mediated by Gα12 signaling involves expression of interleukins-6 and -8, and matrix metalloproteinase-2. J Mol Signal. 9:6.
   PubMedGoogle Scholar
• El-Bakhshawangy NM, El-Nassan HB, Kassab AE, Taher AT. 2018. Design, synthesis and biological evaluation of chromenopyrimidines as potential cytotoxic agents. Future Med Chem. 10(12):1465–1481.
   PubMed Web of Science ®Google Scholar
• Fang W, Li H, Kong L, Niu G, Gao Q, Zhou K, Zheng J, Wu B. 2003. Role of matrix metalloproteinases (MMPs) in tumor invasion and metastasis: serial studies on MMPs and TIMPs. Beijing Da Xue Xue Bao Yi Xue Ban. 35(4):441–443.
   PubMedGoogle Scholar
• Galmarini CM, Mackey JR, Dumontet C. 2002. Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol. 3(7):415–424.
   PubMed Web of Science ®Google Scholar
• Gherghi IC, Girousi ST, Voulgaropoulos AN, Tzimou-Tsitouridou R. 2003. Study of interactions between DNA-ethidium bromide (EB) and DNA-acridine orange (AO), in solution, using hanging mercury drop electrode (HMDE). Talanta. 61(2):103–112.
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science. 281(5381):1309–1312.
   PubMed Web of Science ®Google Scholar
• Heerboth S, Housman G, Leary M, Longacre M, Byler S, Lapinska K, Willbanks A, Sarkar S. 2015. EMT and tumor metastasis. Clin Trans Med. 4:6–6.
   PubMed Web of Science ®Google Scholar
• Jain M, Surin WR, Misra A, Prakash P, Singh V, Khanna V, Kumar S, Siddiqui HH, Raj K, Barthwal MK, et al. 2013. Antithrombotic activity of a newly synthesized coumarin derivative 3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-{2-[3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino]-ethyl}-propionamide. Chem Biol Drug Des. 81(4):499–508.
   PubMed Web of Science ®Google Scholar
• Kaufhold S, Bonavida B. 2014. Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. J Exp Clin Cancer Res. 33(1):62
   PubMed Web of Science ®Google Scholar
• Keri RS, Sasidhar BS, Nagaraja BM, Santos MA. 2015. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents. Eur J Med Chem. 100:257–269.
   PubMed Web of Science ®Google Scholar
• Khan KM, Saify ZS, Khan MZ, Zia U, Choudhary MI, Ur RA, Perveen S, Chohan ZH, Supuran CT. 2004. Synthesis of coumarin derivatives with cytotoxic, antibacterial and antifungal activity. J Enzyme Inhib Med Chem. 19(4):373–379.
   PubMed Web of Science ®Google Scholar
• King TD, Zhang W, Suto MJ, Li Y. 2012. Frizzled7 as an emerging target for cancer therapy. Cell Signal. 24(4):846–851.
   PubMed Web of Science ®Google Scholar
• Kontogiorgis CA, Hadjipavlou-Litina DJ. 2005. Synthesis and antiinflammatory activity of coumarin derivatives. J Med Chem. 48(20):6400–6408.
   PubMed Web of Science ®Google Scholar
• Kostova I. 2005. Synthetic and natural coumarins as cytotoxic agents. Curr Med Chem Anticancer Agents. 5(1):29–46.
   PubMedGoogle Scholar
• Kwon OS, Choi JS, Islam MN, Kim YS, Kim HP. 2011. Inhibition of 5-lipoxygenase and skin inflammation by the aerial parts of Artemisia capillaris and its constituents. Arch Pharm Res. 34(9):1561–1569.
   PubMed Web of Science ®Google Scholar
• Li H, Huang J, Yang B, Xiang T, Yin X, Peng W, Cheng W, Wan J, Luo F, Li H, et al. 2013. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway. Toxicol Appl Pharmacol. 272(1):180–190.
   PubMed Web of Science ®Google Scholar
• MacDonald BT, Tamai K, He X. 2009. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 17(1):9–26.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Takahashi K, Kanayama S, Nakano Y, Imai H, Kibi M, Imahori D, Hasei T, Watanabe T. 2017. Structures of antimutagenic constituents in the peels of Citrus limon. J Nat Med. 71(4):735–744.
   PubMed Web of Science ®Google Scholar
• Merchant N, Nagaraju GP, Rajitha B, Lammata S, Jella KK, Buchwald ZS, Lakka SS, Ali AN. 2017. Matrix metalloproteinases: their functional role in lung cancer. Carcinogenesis. 38(8):766–780.
   PubMed Web of Science ®Google Scholar
• Mirunalini S, Deepalakshmi K, Manimozhi J. 2014. Antiproliferative effect of coumarin by modulating oxidant/antioxidant status and inducing apoptosis in Hep2 cells. Biomed Aging Pathol. 4(2):131–135.
   Google Scholar
• Morsy SA, Farahat AA, Nasr MNA, Tantawy AS. 2017. Synthesis, molecular modeling and anticancer activity of new coumarin containing compounds. Saudi Pharm J. 25(6):873–883.
   PubMed Web of Science ®Google Scholar
• Nagaraj NS, Datta PK. 2010. Targeting the transforming growth factor-beta signaling pathway in human cancer. Expert Opin Investig Drugs. 19(1):77–91.
   PubMed Web of Science ®Google Scholar
• Najmanová I, Doseděl M, Hrdina R, Anzenbacher P, Filipský T, Říha M, Mladěnka P. 2015. Cardiovascular effects of coumarins besides their antioxidant activity. Curr Top Med Chem. 15(9):830–849.
   PubMed Web of Science ®Google Scholar
• Nargotra A, Sharma S, Alam MI, Ahmed Z, Bhagat A, Taneja SC, Qazi GN, Koul S. 2011. In silico identification of viper phospholipaseA2 inhibitors: validation by in vitro, in vivo studies. J Mol Model. 17(12):3063–3073.
   PubMed Web of Science ®Google Scholar
• Nawrocki-Raby B, Gilles C, Polette M, Martinella-Catusse C, Bonnet N, Puchelle E, Foidart JM, Roy FV, Birembaut P. 2003. E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. Am J Pathol. 163(2):653–661.
   PubMed Web of Science ®Google Scholar
• Neyts J, Clercq ED, Singha R, Chang YH, Das AR, Chakraborty SK, Hong SC, Tsay SC, Hsu MH, Hwu JR. 2009. Structure-activity relationship of new anti-hepatitis C virus agents: heterobicycle-coumarin conjugates. J Med Chem. 52(5):1486–1490.
   PubMed Web of Science ®Google Scholar
• Pajaniradje S, Mohankumar K, Pamidimukkala R, Subramanian S, Rajagopalan R. 2014. Antiproliferative and apoptotic effects of Sesbania grandiflora leaves in human cancer cells. Biomed Res Int. 2014:474953.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Pisani P, Ferlay J. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 54(4):594–606.
   PubMed Web of Science ®Google Scholar
• Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJ. 1998. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. Br J Cancer. 78(11):1495–1502.
   PubMed Web of Science ®Google Scholar
• Patil PO, Bari SB, Firke SD, Deshmukh PK, Donda ST, Patil DA. 2013. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer’s disease. Bioorg Med Chem. 21(9):2434–2450.
   PubMed Web of Science ®Google Scholar
• Penta S. 2016. Advances in structure and activity relationship of coumarin derivatives. Massachusetts (MA): Academic Press. Chapter 3, Antitumor Agents; p. 47–76.
   Google Scholar
• Safranek J, Pesta M, Holubec L, Kulda V, Dreslerova J, Vrzalova J, Topolcan O, Pesek M, Finek J, Treska V. 2009. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease. Anticancer Res. 29(7):2513–2517.
   PubMed Web of Science ®Google Scholar
• Sashidhara KV, Kumar A, Kumar M, Sarkar J, Sinha S. 2010. Synthesis and in vitro evaluation of novel coumarin-chalcone hybrids as potential anticancer agents. Bioorg Med Chem Lett. 20(24):7205–7211.
   PubMed Web of Science ®Google Scholar
• Shirasaka T. 2008. Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas. Jpn J Clin Oncol. 39(1):2–15.
   PubMed Web of Science ®Google Scholar
• Simon HU, Haj-Yehia A, Levi-Schaffer F. 2000. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 5(5):415–418.
   PubMed Web of Science ®Google Scholar
• Xu J, Lamouille S, Derynck R. 2009. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19(2):156–172.
   PubMed Web of Science ®Google Scholar
• Zappa C, Mousa SA. 2016. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 5(3):288–300.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang F, Xu P, Miao C, Zeng X, Cui X, Lu C, Xie H, Yin H, Chen F, et al. 2014. Perfluorooctanoic acid stimulates breast cancer cells invasion and up-regulates matrix metalloproteinase-2/-9 expression mediated by activating NF-kappaB. Toxicol Lett. 229(1):118–125.
   PubMed Web of Science ®Google Scholar
• Zhu YY, Huang HY, Wu YL. 2015. Anticancer and apoptotic activities of oleanolic acid are mediated through cell cycle arrest and disruption of mitochondrial membrane potential in HepG2 human hepatocellular carcinoma cells. Mol Med Rep. 12(4):5012–5018.
   PubMed Web of Science ®Google Scholar